Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
Saved in:
| Title: | Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. |
|---|---|
| Authors: | Khoury HJ; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia., Collins RH Jr; Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas., Blum W; Department of Hematology, The Ohio State University, Columbus, Ohio., Stiff PS; Department of Medicine, Loyola University, Maywood, Illinois., Elias L; Geron Corporation, Menlo Park, California., Lebkowski JS; Asterias Biotherapeutics Inc, Menlo Park, California., Reddy A; Geron Corporation, Menlo Park, California., Nishimoto KP; Asterias Biotherapeutics Inc, Menlo Park, California., Sen D; Asterias Biotherapeutics Inc, Menlo Park, California., Wirth ED 3rd; Asterias Biotherapeutics Inc, Menlo Park, California., Case CC; Asterias Biotherapeutics Inc, Menlo Park, California., DiPersio JF; Department of Oncology, Washington University School of Medicine, St. Louis, Missouri. |
| Source: | Cancer [Cancer] 2017 Aug 15; Vol. 123 (16), pp. 3061-3072. Date of Electronic Publication: 2017 Apr 14. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.30696 |
